Dr. Eric Lee Tatar, MD

Dr. Tatar practices at White Plains Hospital in White Plains, New York, part of Montefiore Einstein.

Dr. Tatar's NPI, 1134179393, was assigned on May 10, 2006. Dr. Tatar graduated from Albert Einstein College of Medicine of Yeshiva University in 2000. Dr. Tatar holds New York license 239151.

Dr. Tatar's primary practice is White Plains Hospital, at Davis Ave at E Post Road, White Plains, NY 10601 in Westchester County. The practice phone is (914) 681-0600. Dr. Tatar also practices at White Plains Hospital, 41 E Post Rd, White Plains, NY 10601.

Dr. Tatar's primary practice is White Plains Hospital in White Plains, New York, part of Montefiore Einstein. Dr. Tatar is also affiliated with Montefiore Nyack Hospital. The medical group on file is Highland Medical Group. Dmand AI also links Dr. Tatar to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tatar practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tatar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tatar is licensed in New York.

CMS data shows 1,212 Medicare services from Dr. Tatar across 20 procedure codes in 2024, for 575 Medicare patients. Medicare paid $138,365 for them.

CMS counts 575 Medicare patients who saw Dr. Tatar in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tatar's median patient age at 58, with 50% women.

In 2024, Dr. Tatar wrote 1,264 Medicare Part D claims for 256 patients. 85% of them were for generic drugs. CMS names the drug for 1,084 of them, across 23 drugs with 11 or more claims each, at $231,034 in total drug cost. In 2023, CMS named 776 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 29 out of 100 for Dr. Tatar for performance year 2024, reported individually. Dr. Tatar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tatar as offering telehealth. CMS counts 143 procedures of colonoscopy by Dr. Tatar, more than 88% of the clinicians it reports for that procedure.

CMS Open Payments shows 593 general payments to Dr. Tatar from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Medtronic, Inc. paid the most, $35,463.

Dr. Tatar graduated from Albert Einstein College of Medicine of Yeshiva University in 2000.